A new method enables the detection of the onset of Parkinson's disease before the onset of brain damage and symptoms such as tremors. A protein in the brain water can indicate early on Parkinson's. Experts describe the method as a "game changer" for the diagnosis, research and treatment of Parkinson's. The findings are expected to have implications for new therapies.
Boxing is a popular sport that has recently become more popular due to its positive effects on people suffering from Parkinson's disease. It has even been recognized to lead to a significant improvement in walking speed in people with Parkinson's disease.
The possible effects of brain implants on personality is an active area of research, and while some studies show positive changes in self-perception and identity, there are also concerns about unwanted effects.
A pilot study shows significantly improved motor parkinsonian symptoms without the dyskinesias usually caused by the transplant
It is not the first time that the Parkinson's Journal has reported on cell therapies at this point, but previous attempts in this direction have not been convincing.
The first tests of this promising therapy in people with Parkinson's, in which the diseased brain cells are replaced by healthy nerve cells, will start as early as January 2023. Eight brave people from England and Sweden will be the first people to have this new method tested on them. And if everything goes well, there is a very good chance that stem cell therapy will be rolled out in five years.
light at the end of the tunnel
Stem cell therapy for Parkinson's disease has received approval to enter a clinical trial in Sweden
James Parkinson wrongly believed that the disease had no effect on the mind and psyche of those affected.
That was a fatal misjudgment, since new scientific studies have shown that every third Parkinson's patient develops dementia in the course of the disease.
However, this so-called Parkinson's dementia usually only occurs in the late stages of the disease and thus mainly, but not exclusively, affects patients of advanced age
But what actually is dementia?
Inbrija – first experiences
On July 8, 2022, we published an interview with 2 American women who have been using Inbrija for 3 years. In the meantime, the drug has also been approved in Germany and we have the first field reports.
If you haven't read the article or seen the interview, you can catch up here: https://parkinson-journal.de/inbrija
The Angry Professor's Appeal
dr Ray Dorsey is Professor of Neurology and Director of the Center for Human Experimental Therapeutics at the University of Rochester in the USA. And he is angry and disappointed in his colleagues.
The trigger is an international Parkinson's congress that was held in Madrid a few days ago and was attended by Dr. Dorsey attended. The most recent studies presented there focused mainly on the genetic cause of Parkinson's.
I feel for dr. Ray Dorsey. You're probably wondering why this is the cause of an outburst from one of the world's leading neurologists and Parkinson's experts. Genetic research in Parkinson's has made great strides.
The fatal thing is that most researchers concentrate on a topic that only
Affects 17 percent of people with Parkinson's disease.